Skip to content

Dietary Intake and Circulating Levels of Branched Chain Amino Acids

Short-term Dietary Intake and Branched Chain Amino Acids

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02110602
Enrollment
5
Registered
2014-04-10
Start date
2014-04-30
Completion date
2014-08-31
Last updated
2016-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dietary Intake of Branched Chain Amino Acids

Keywords

Nutrition

Brief summary

The investigators are conducting this research study to find out if eating low or high levels of specific amino acids changes the levels of these same amino acids in the blood. Amino acids are the building blocks of protein that are normally found in food. The amino acids the investigators are studying are called branched chain amino acids. The investigators will look at the levels (amount) of branched chain amino acids in blood before and after consumption of specially prepared meals. The investigators hypothesize that circulating branch chain amino acid (BCAA) levels will be lower following a low BCAA-content diet compared with a high BCAA-content diet.

Interventions

OTHERDiet high in amino acid levels

Meals will be prepared in the Clinical Research Center Metabolism & Nutrition Metabolic Kitchen, and participants will eat only this food during the controlled-diet periods of the study. The diets will contain equivalent calories (matched to the requirements of each participant) and either a low or high percentage of all BCAAs relative to protein content.

OTHERDiet low in amino acid levels

Meals will be prepared in the Clinical Research Center Metabolism & Nutrition Metabolic Kitchen, and participants will eat only this food during the controlled-diet periods of the study. The diets will contain equivalent calories (matched to the requirements of each participant) and either a low or high percentage of all BCAAs relative to protein content.

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Adult males * Ages 20-40 * Healthy

Exclusion criteria

* Age less than 20 or greater than 40 * Female sex * Use of medications and herbal or vitamin supplements during the study or less than one month prior to enrollment in the study * Body mass index (BMI) less than 20 or greater than 25 * Changes of more than 5 pounds in weight (increase or decrease) during the month prior to enrollment in the study * Participation in more than 300 minutes of exercise per week during the month prior to enrollment in the study or plans for changes in exercise level during the study * Known diabetes or pre-diabetes (based on prior diagnoses; use of medications to lower glucose; or fasting blood glucose \> 100mg/dL at screening) * Untreated hypertension (defined as systolic blood pressure \> 140mmHg and diastolic blood pressure \> 90mmHg) * Use of nicotine-containing products, including those inhaled, chewed, or patches during the study. * Use of drugs of abuse. * Conditions causing intestinal malabsorption, including celiac disease or a history of intestinal or gastric surgery * Restrictions that prevent adherence to standardized meals or unwillingness to adhere to a pre-specified meal plan, including abstinence from alcohol and limitation to 1 caffeinated beverage per day * Known anemia (men, hematocrit \< 38%) based on prior testing

Design outcomes

Primary

MeasureTime frameDescription
Comparison of Branch Chain Amino Acid levels following diet interventions4 daysA comparison of branched chain amino acid levels (as measured by mass spectrometry) following 4 days of a low and following 4 days of a high BCAA-content diet

Secondary

MeasureTime frame
Change in fasting BCAA levels from native dietary intake to completion of diet intervention4 days

Other

MeasureTime frame
Comparison of fasting glucose and insulin levels following diet interventions4 days
Change in fasting glucose and insulin levels from native dietary intake to completion of diet intervention4 days
Tolerance of diet interventions4 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026